Literature DB >> 21488055

PCP chemoprophylaxis is essential for lymphopenic dermatomyositis patients treated with immunomodulators.

Petros Efthimiou, Hiren Pokharna, Manil Kukar, Karen Hennessey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21488055     DOI： 10.1002/mus.21997

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  5 in total

1.  Infections and the relationship to treatment in neuromuscular autoimmunity.

Authors:  Devin E Prior; Emily Nurre; Stephanie L Roller; David Kline; Ramit Panara; Amro M Stino; John A Davis; Miriam L Freimer; W David Arnold
Journal:  Muscle Nerve       Date:  2017-12-20       Impact factor: 3.217

2.  Red fist and muscle weakness with a rare complication.

Authors:  Iris van Groeningen; Joyce Arnoldus; Roos Perenboom; Alexandre Voskuyl
Journal:  BMJ Case Rep       Date:  2014-02-20

Review 3.  Idiopathic inflammatory myopathies.

Authors:  Mazen M Dimachkie; Richard J Barohn; Anthony A Amato
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

Review 4.  Autoimmune Myopathies: Updates on Evaluation and Treatment.

Authors:  Emer R McGrath; Christopher T Doughty; Anthony A Amato
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

5.  The RIG-I pathway is involved in peripheral T cell lymphopenia in patients with dermatomyositis.

Authors:  Lu Zhang; Qisheng Xia; Wenli Li; Qinglin Peng; Hanbo Yang; Xin Lu; Guochun Wang
Journal:  Arthritis Res Ther       Date:  2019-05-29       Impact factor: 5.156
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.